The Effect of Bevacizumab (Avastin) on Pterygium

• Status: Completed
• Trial end date: 2010-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether local injection of bevacizumab might halt and or cause regression of pterygium growth. This may enable earlier treatment and prevention of pterygium growth into the patient's line of sight thereby limiting the need for surgery and improving quality of life for patients with pterygia.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Alabama at Birmingham
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• 19 years of age and older

• Diagnosis of pterygia

• healthy enough to make scheduled follow-up visits

Exclusion Criteria:

• Women of childbearing potential and males who plan to father a child during their participation in the study will be excluded from the study.